Close Menu

The speed with which funds from the stimulus package are given out by the NIH or NSF won't comprise the quality of the research, reports Science. To get the money out the door quickly and into researchers' hands, the funding agencies will look to the existing applicant pool and NIH is also soliciting for two-year challenge grants with an application deadline in late April. "Our instructions to the panels haven't changed," says Peter Marsh, the director of NSF's Division of Mathematical Sciences.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Bloomberg reports AstraZeneca may conduct another study of its candidate SARS-CoV-2 vaccine after dosing error.

Moderna is applying for an Emergency Use Authorization for its coronavirus vaccine, according to the New York Times.

The National Health Service is to conduct a trial of Grail's blood-based screening test for cancer.

In PLOS this week: somatic mutation patterns of glioblastomas among Lebanese patients, phenome-wide study using UK Biobank data, and more.